Gregory R. Friberg - 31 Dec 2025 Form 5 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief R&D Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
31 Dec 2025
Net transactions value
+$18,123
Form type
5
Filing time
13 Feb 2026, 18:54:26 UTC
Previous filing
02 Oct 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Friberg Gregory R EVP, Chief R&D Officer C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL /s/ Tae Sang Yoo, Attorney-in-Fact 13 Feb 2026 0002038768

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $18,123 +398 +0.91% $45.54 43,904 31 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan.